CAMP Continuation Study/Phase 2

加州大学圣地亚哥分校（UCSD）和Kaiser Permanente (KP) San Diego作为儿童哮喘管理项目（CAMP）试验和CAMP持续研究（CAMPCS）的8个临床中心之一，自1991年合同签订和授予以来一直参与其中。对于CAMP，我们的网站随机选择了122名5-12岁的儿童。轻度至中度哮喘年龄，其中40%为少数民族。

The University of California at San Diego (UCSD) and Kaiser Permanente (KP) San Diego have participated as one of the 8 Clinical Centers in the Childhood Asthma Management Program (CAMP) Trial and CAMP Continuation Study (CAMPCS) since contract inception and award in 1991. For CAMP, our site randomized the required 122 children 5-12.years of age with mild to moderate asthma of which 40% were from ethnic minorities. Our research facilities are well equipped and conducive to perform all aspects of CAMPCS/2. The scientific portion of the study is part of the CAMPCS/2 multicenter proposal provided in the Washington University application. We at the UCSD/KP Clinical Center are willing to participate in the additional follow-up requested by this application and our track record as noted above is supportive of our ability to do so.